CAM
AMAG

Capstone Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Capstone Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$230K Sell
12,476
-510
-4% -$10.1K 0.01% 1441
2017
Q1 		$293K Sell
12,986
-1,670
-11% -$40K 0.01% 1306
2016
Q4 		$510K Buy
14,656
+3,990
+37% +$119K 0.01% 915
2016
Q3 		$261K Sell
10,666
-210
-2% -$5.25K 0.01% 1405
2016
Q2 		$260K Buy
10,876
+530
+5% +$12.2K 0.01% 1373
2016
Q1 		$242K Buy
+10,346
New +$246K 0.01% 1392

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Capstone Asset Management's AMAG Position: Q2 2017 in Review

Capstone Asset Management reduced its AMAG Pharmaceuticals (AMAG) stake by 3.9% in Q2 2017, selling an estimated $10.1K and leaving 12,476 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #1441.

Capstone Asset Management first reported a position in AMAG in Q1 2016 and has held it in 6 quarters since. The position peaked at $510K in Q4 2016. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • Capstone Asset Management held 12,476 shares of AMAG Pharmaceuticals worth $230K as of Q2 2017.
  • Capstone Asset Management sold 510 AMAG Pharmaceuticals shares in Q2 2017, an estimated $10.1K.
  • AMAG Pharmaceuticals made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1441 holding.
  • Capstone Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2016 and has held it in 6 quarters since.
  • Capstone Asset Management's AMAG Pharmaceuticals position peaked at $510K in Q4 2016.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.